0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Antipyretic and Analgesic Drugs Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-25O12872
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Antipyretic and Analgesic Drugs Market Research Report 2023
BUY CHAPTERS

Global Antipyretic and Analgesic Drugs Market Research Report 2025

Code: QYRE-Auto-25O12872
Report
May 2025
Pages:100
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Antipyretic and Analgesic Drugs Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Antipyretic and Analgesic Drugs Market

Antipyretic and Analgesic Drugs Market

The global market for Antipyretic and Analgesic Drugs was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Antipyretic and Analgesic Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antipyretic and Analgesic Drugs.
The Antipyretic and Analgesic Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Antipyretic and Analgesic Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antipyretic and Analgesic Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Antipyretic and Analgesic Drugs Market Report

Report Metric Details
Report Name Antipyretic and Analgesic Drugs Market
CAGR 5%
Segment by Type
Segment by Application
  • Hospital
  • Clinic
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Mallinckrodt, SKPL, Pfizer, Sanofi, Bayer, China National Medicines Guorui Pharmaceutical, Baotai Pharmaceutical, Huaan Pharmaceutical, Yuanhe Pharmaceutical, Heping Pharmaceutical, Hongxing Pharmaceutical, Xinhui Pharmaceutical, Dingchang Pharmaceutical, Topfond Pharmaceutical, Taile Pharmaceutical, Kys Pharm, China Resources Double-Crane Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Antipyretic and Analgesic Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Antipyretic and Analgesic Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Antipyretic and Analgesic Drugs Market report?

Ans: The main players in the Antipyretic and Analgesic Drugs Market are Mallinckrodt, SKPL, Pfizer, Sanofi, Bayer, China National Medicines Guorui Pharmaceutical, Baotai Pharmaceutical, Huaan Pharmaceutical, Yuanhe Pharmaceutical, Heping Pharmaceutical, Hongxing Pharmaceutical, Xinhui Pharmaceutical, Dingchang Pharmaceutical, Topfond Pharmaceutical, Taile Pharmaceutical, Kys Pharm, China Resources Double-Crane Pharmaceutical

What are the Application segmentation covered in the Antipyretic and Analgesic Drugs Market report?

Ans: The Applications covered in the Antipyretic and Analgesic Drugs Market report are Hospital, Clinic

What are the Type segmentation covered in the Antipyretic and Analgesic Drugs Market report?

Ans: The Types covered in the Antipyretic and Analgesic Drugs Market report are Ibuprofen, Paracetamol, Analgin, Naproxen, Aspirin, Others

Recommended Reports

Pain Relief Drugs

APIs & Analgesics

Broader Pharma Market

1 Antipyretic and Analgesic Drugs Market Overview
1.1 Product Definition
1.2 Antipyretic and Analgesic Drugs by Type
1.2.1 Global Antipyretic and Analgesic Drugs Market Value Comparison by Type (2024 VS 2031)
1.2.2 Ibuprofen
1.2.3 Paracetamol
1.2.4 Analgin
1.2.5 Naproxen
1.2.6 Aspirin
1.2.7 Others
1.3 Antipyretic and Analgesic Drugs by Application
1.3.1 Global Antipyretic and Analgesic Drugs Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Antipyretic and Analgesic Drugs Market Size Estimates and Forecasts
1.4.1 Global Antipyretic and Analgesic Drugs Revenue 2020-2031
1.4.2 Global Antipyretic and Analgesic Drugs Sales 2020-2031
1.4.3 Global Antipyretic and Analgesic Drugs Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Antipyretic and Analgesic Drugs Market Competition by Manufacturers
2.1 Global Antipyretic and Analgesic Drugs Sales Market Share by Manufacturers (2020-2025)
2.2 Global Antipyretic and Analgesic Drugs Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Antipyretic and Analgesic Drugs Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Antipyretic and Analgesic Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Antipyretic and Analgesic Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Antipyretic and Analgesic Drugs, Product Type & Application
2.7 Global Key Manufacturers of Antipyretic and Analgesic Drugs, Date of Enter into This Industry
2.8 Global Antipyretic and Analgesic Drugs Market Competitive Situation and Trends
2.8.1 Global Antipyretic and Analgesic Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Antipyretic and Analgesic Drugs Players Market Share by Revenue
2.8.3 Global Antipyretic and Analgesic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Antipyretic and Analgesic Drugs Market Scenario by Region
3.1 Global Antipyretic and Analgesic Drugs Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Antipyretic and Analgesic Drugs Sales by Region: 2020-2031
3.2.1 Global Antipyretic and Analgesic Drugs Sales by Region: 2020-2025
3.2.2 Global Antipyretic and Analgesic Drugs Sales by Region: 2026-2031
3.3 Global Antipyretic and Analgesic Drugs Revenue by Region: 2020-2031
3.3.1 Global Antipyretic and Analgesic Drugs Revenue by Region: 2020-2025
3.3.2 Global Antipyretic and Analgesic Drugs Revenue by Region: 2026-2031
3.4 North America Antipyretic and Analgesic Drugs Market Facts & Figures by Country
3.4.1 North America Antipyretic and Analgesic Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Antipyretic and Analgesic Drugs Sales by Country (2020-2031)
3.4.3 North America Antipyretic and Analgesic Drugs Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Antipyretic and Analgesic Drugs Market Facts & Figures by Country
3.5.1 Europe Antipyretic and Analgesic Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Antipyretic and Analgesic Drugs Sales by Country (2020-2031)
3.5.3 Europe Antipyretic and Analgesic Drugs Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Antipyretic and Analgesic Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Antipyretic and Analgesic Drugs Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Antipyretic and Analgesic Drugs Sales by Region (2020-2031)
3.6.3 Asia Pacific Antipyretic and Analgesic Drugs Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Antipyretic and Analgesic Drugs Market Facts & Figures by Country
3.7.1 Latin America Antipyretic and Analgesic Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Antipyretic and Analgesic Drugs Sales by Country (2020-2031)
3.7.3 Latin America Antipyretic and Analgesic Drugs Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Antipyretic and Analgesic Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Antipyretic and Analgesic Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Antipyretic and Analgesic Drugs Sales by Country (2020-2031)
3.8.3 Middle East and Africa Antipyretic and Analgesic Drugs Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Antipyretic and Analgesic Drugs Sales by Type (2020-2031)
4.1.1 Global Antipyretic and Analgesic Drugs Sales by Type (2020-2025)
4.1.2 Global Antipyretic and Analgesic Drugs Sales by Type (2026-2031)
4.1.3 Global Antipyretic and Analgesic Drugs Sales Market Share by Type (2020-2031)
4.2 Global Antipyretic and Analgesic Drugs Revenue by Type (2020-2031)
4.2.1 Global Antipyretic and Analgesic Drugs Revenue by Type (2020-2025)
4.2.2 Global Antipyretic and Analgesic Drugs Revenue by Type (2026-2031)
4.2.3 Global Antipyretic and Analgesic Drugs Revenue Market Share by Type (2020-2031)
4.3 Global Antipyretic and Analgesic Drugs Price by Type (2020-2031)
5 Segment by Application
5.1 Global Antipyretic and Analgesic Drugs Sales by Application (2020-2031)
5.1.1 Global Antipyretic and Analgesic Drugs Sales by Application (2020-2025)
5.1.2 Global Antipyretic and Analgesic Drugs Sales by Application (2026-2031)
5.1.3 Global Antipyretic and Analgesic Drugs Sales Market Share by Application (2020-2031)
5.2 Global Antipyretic and Analgesic Drugs Revenue by Application (2020-2031)
5.2.1 Global Antipyretic and Analgesic Drugs Revenue by Application (2020-2025)
5.2.2 Global Antipyretic and Analgesic Drugs Revenue by Application (2026-2031)
5.2.3 Global Antipyretic and Analgesic Drugs Revenue Market Share by Application (2020-2031)
5.3 Global Antipyretic and Analgesic Drugs Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Mallinckrodt
6.1.1 Mallinckrodt Company Information
6.1.2 Mallinckrodt Description and Business Overview
6.1.3 Mallinckrodt Antipyretic and Analgesic Drugs Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Mallinckrodt Antipyretic and Analgesic Drugs Product Portfolio
6.1.5 Mallinckrodt Recent Developments/Updates
6.2 SKPL
6.2.1 SKPL Company Information
6.2.2 SKPL Description and Business Overview
6.2.3 SKPL Antipyretic and Analgesic Drugs Sales, Revenue and Gross Margin (2020-2025)
6.2.4 SKPL Antipyretic and Analgesic Drugs Product Portfolio
6.2.5 SKPL Recent Developments/Updates
6.3 Pfizer
6.3.1 Pfizer Company Information
6.3.2 Pfizer Description and Business Overview
6.3.3 Pfizer Antipyretic and Analgesic Drugs Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Pfizer Antipyretic and Analgesic Drugs Product Portfolio
6.3.5 Pfizer Recent Developments/Updates
6.4 Sanofi
6.4.1 Sanofi Company Information
6.4.2 Sanofi Description and Business Overview
6.4.3 Sanofi Antipyretic and Analgesic Drugs Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Sanofi Antipyretic and Analgesic Drugs Product Portfolio
6.4.5 Sanofi Recent Developments/Updates
6.5 Bayer
6.5.1 Bayer Company Information
6.5.2 Bayer Description and Business Overview
6.5.3 Bayer Antipyretic and Analgesic Drugs Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Bayer Antipyretic and Analgesic Drugs Product Portfolio
6.5.5 Bayer Recent Developments/Updates
6.6 China National Medicines Guorui Pharmaceutical
6.6.1 China National Medicines Guorui Pharmaceutical Company Information
6.6.2 China National Medicines Guorui Pharmaceutical Description and Business Overview
6.6.3 China National Medicines Guorui Pharmaceutical Antipyretic and Analgesic Drugs Sales, Revenue and Gross Margin (2020-2025)
6.6.4 China National Medicines Guorui Pharmaceutical Antipyretic and Analgesic Drugs Product Portfolio
6.6.5 China National Medicines Guorui Pharmaceutical Recent Developments/Updates
6.7 Baotai Pharmaceutical
6.7.1 Baotai Pharmaceutical Company Information
6.7.2 Baotai Pharmaceutical Description and Business Overview
6.7.3 Baotai Pharmaceutical Antipyretic and Analgesic Drugs Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Baotai Pharmaceutical Antipyretic and Analgesic Drugs Product Portfolio
6.7.5 Baotai Pharmaceutical Recent Developments/Updates
6.8 Huaan Pharmaceutical
6.8.1 Huaan Pharmaceutical Company Information
6.8.2 Huaan Pharmaceutical Description and Business Overview
6.8.3 Huaan Pharmaceutical Antipyretic and Analgesic Drugs Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Huaan Pharmaceutical Antipyretic and Analgesic Drugs Product Portfolio
6.8.5 Huaan Pharmaceutical Recent Developments/Updates
6.9 Yuanhe Pharmaceutical
6.9.1 Yuanhe Pharmaceutical Company Information
6.9.2 Yuanhe Pharmaceutical Description and Business Overview
6.9.3 Yuanhe Pharmaceutical Antipyretic and Analgesic Drugs Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Yuanhe Pharmaceutical Antipyretic and Analgesic Drugs Product Portfolio
6.9.5 Yuanhe Pharmaceutical Recent Developments/Updates
6.10 Heping Pharmaceutical
6.10.1 Heping Pharmaceutical Company Information
6.10.2 Heping Pharmaceutical Description and Business Overview
6.10.3 Heping Pharmaceutical Antipyretic and Analgesic Drugs Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Heping Pharmaceutical Antipyretic and Analgesic Drugs Product Portfolio
6.10.5 Heping Pharmaceutical Recent Developments/Updates
6.11 Hongxing Pharmaceutical
6.11.1 Hongxing Pharmaceutical Company Information
6.11.2 Hongxing Pharmaceutical Description and Business Overview
6.11.3 Hongxing Pharmaceutical Antipyretic and Analgesic Drugs Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Hongxing Pharmaceutical Antipyretic and Analgesic Drugs Product Portfolio
6.11.5 Hongxing Pharmaceutical Recent Developments/Updates
6.12 Xinhui Pharmaceutical
6.12.1 Xinhui Pharmaceutical Company Information
6.12.2 Xinhui Pharmaceutical Description and Business Overview
6.12.3 Xinhui Pharmaceutical Antipyretic and Analgesic Drugs Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Xinhui Pharmaceutical Antipyretic and Analgesic Drugs Product Portfolio
6.12.5 Xinhui Pharmaceutical Recent Developments/Updates
6.13 Dingchang Pharmaceutical
6.13.1 Dingchang Pharmaceutical Company Information
6.13.2 Dingchang Pharmaceutical Description and Business Overview
6.13.3 Dingchang Pharmaceutical Antipyretic and Analgesic Drugs Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Dingchang Pharmaceutical Antipyretic and Analgesic Drugs Product Portfolio
6.13.5 Dingchang Pharmaceutical Recent Developments/Updates
6.14 Topfond Pharmaceutical
6.14.1 Topfond Pharmaceutical Company Information
6.14.2 Topfond Pharmaceutical Description and Business Overview
6.14.3 Topfond Pharmaceutical Antipyretic and Analgesic Drugs Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Topfond Pharmaceutical Antipyretic and Analgesic Drugs Product Portfolio
6.14.5 Topfond Pharmaceutical Recent Developments/Updates
6.15 Taile Pharmaceutical
6.15.1 Taile Pharmaceutical Company Information
6.15.2 Taile Pharmaceutical Description and Business Overview
6.15.3 Taile Pharmaceutical Antipyretic and Analgesic Drugs Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Taile Pharmaceutical Antipyretic and Analgesic Drugs Product Portfolio
6.15.5 Taile Pharmaceutical Recent Developments/Updates
6.16 Kys Pharm
6.16.1 Kys Pharm Company Information
6.16.2 Kys Pharm Description and Business Overview
6.16.3 Kys Pharm Antipyretic and Analgesic Drugs Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Kys Pharm Antipyretic and Analgesic Drugs Product Portfolio
6.16.5 Kys Pharm Recent Developments/Updates
6.17 China Resources Double-Crane Pharmaceutical
6.17.1 China Resources Double-Crane Pharmaceutical Company Information
6.17.2 China Resources Double-Crane Pharmaceutical Description and Business Overview
6.17.3 China Resources Double-Crane Pharmaceutical Antipyretic and Analgesic Drugs Sales, Revenue and Gross Margin (2020-2025)
6.17.4 China Resources Double-Crane Pharmaceutical Antipyretic and Analgesic Drugs Product Portfolio
6.17.5 China Resources Double-Crane Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Antipyretic and Analgesic Drugs Industry Chain Analysis
7.2 Antipyretic and Analgesic Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Antipyretic and Analgesic Drugs Production Mode & Process Analysis
7.4 Antipyretic and Analgesic Drugs Sales and Marketing
7.4.1 Antipyretic and Analgesic Drugs Sales Channels
7.4.2 Antipyretic and Analgesic Drugs Distributors
7.5 Antipyretic and Analgesic Drugs Customer Analysis
8 Antipyretic and Analgesic Drugs Market Dynamics
8.1 Antipyretic and Analgesic Drugs Industry Trends
8.2 Antipyretic and Analgesic Drugs Market Drivers
8.3 Antipyretic and Analgesic Drugs Market Challenges
8.4 Antipyretic and Analgesic Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Antipyretic and Analgesic Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Antipyretic and Analgesic Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Antipyretic and Analgesic Drugs Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Antipyretic and Analgesic Drugs Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Antipyretic and Analgesic Drugs Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Antipyretic and Analgesic Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Antipyretic and Analgesic Drugs Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Antipyretic and Analgesic Drugs Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Antipyretic and Analgesic Drugs, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Antipyretic and Analgesic Drugs, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Antipyretic and Analgesic Drugs, Product Type & Application
 Table 12. Global Key Manufacturers of Antipyretic and Analgesic Drugs, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Antipyretic and Analgesic Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antipyretic and Analgesic Drugs as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Antipyretic and Analgesic Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Antipyretic and Analgesic Drugs Sales by Region (2020-2025) & (K Units)
 Table 18. Global Antipyretic and Analgesic Drugs Sales Market Share by Region (2020-2025)
 Table 19. Global Antipyretic and Analgesic Drugs Sales by Region (2026-2031) & (K Units)
 Table 20. Global Antipyretic and Analgesic Drugs Sales Market Share by Region (2026-2031)
 Table 21. Global Antipyretic and Analgesic Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Antipyretic and Analgesic Drugs Revenue Market Share by Region (2020-2025)
 Table 23. Global Antipyretic and Analgesic Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Antipyretic and Analgesic Drugs Revenue Market Share by Region (2026-2031)
 Table 25. North America Antipyretic and Analgesic Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Antipyretic and Analgesic Drugs Sales by Country (2020-2025) & (K Units)
 Table 27. North America Antipyretic and Analgesic Drugs Sales by Country (2026-2031) & (K Units)
 Table 28. North America Antipyretic and Analgesic Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Antipyretic and Analgesic Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Antipyretic and Analgesic Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Antipyretic and Analgesic Drugs Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Antipyretic and Analgesic Drugs Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Antipyretic and Analgesic Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Antipyretic and Analgesic Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Antipyretic and Analgesic Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Antipyretic and Analgesic Drugs Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Antipyretic and Analgesic Drugs Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Antipyretic and Analgesic Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Antipyretic and Analgesic Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Antipyretic and Analgesic Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Antipyretic and Analgesic Drugs Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Antipyretic and Analgesic Drugs Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Antipyretic and Analgesic Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Antipyretic and Analgesic Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Antipyretic and Analgesic Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Antipyretic and Analgesic Drugs Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Antipyretic and Analgesic Drugs Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Antipyretic and Analgesic Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Antipyretic and Analgesic Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Antipyretic and Analgesic Drugs Sales (K Units) by Type (2020-2025)
 Table 51. Global Antipyretic and Analgesic Drugs Sales (K Units) by Type (2026-2031)
 Table 52. Global Antipyretic and Analgesic Drugs Sales Market Share by Type (2020-2025)
 Table 53. Global Antipyretic and Analgesic Drugs Sales Market Share by Type (2026-2031)
 Table 54. Global Antipyretic and Analgesic Drugs Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Antipyretic and Analgesic Drugs Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Antipyretic and Analgesic Drugs Revenue Market Share by Type (2020-2025)
 Table 57. Global Antipyretic and Analgesic Drugs Revenue Market Share by Type (2026-2031)
 Table 58. Global Antipyretic and Analgesic Drugs Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Antipyretic and Analgesic Drugs Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Antipyretic and Analgesic Drugs Sales (K Units) by Application (2020-2025)
 Table 61. Global Antipyretic and Analgesic Drugs Sales (K Units) by Application (2026-2031)
 Table 62. Global Antipyretic and Analgesic Drugs Sales Market Share by Application (2020-2025)
 Table 63. Global Antipyretic and Analgesic Drugs Sales Market Share by Application (2026-2031)
 Table 64. Global Antipyretic and Analgesic Drugs Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Antipyretic and Analgesic Drugs Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Antipyretic and Analgesic Drugs Revenue Market Share by Application (2020-2025)
 Table 67. Global Antipyretic and Analgesic Drugs Revenue Market Share by Application (2026-2031)
 Table 68. Global Antipyretic and Analgesic Drugs Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Antipyretic and Analgesic Drugs Price (US$/Unit) by Application (2026-2031)
 Table 70. Mallinckrodt Company Information
 Table 71. Mallinckrodt Description and Business Overview
 Table 72. Mallinckrodt Antipyretic and Analgesic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Mallinckrodt Antipyretic and Analgesic Drugs Product
 Table 74. Mallinckrodt Recent Developments/Updates
 Table 75. SKPL Company Information
 Table 76. SKPL Description and Business Overview
 Table 77. SKPL Antipyretic and Analgesic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. SKPL Antipyretic and Analgesic Drugs Product
 Table 79. SKPL Recent Developments/Updates
 Table 80. Pfizer Company Information
 Table 81. Pfizer Description and Business Overview
 Table 82. Pfizer Antipyretic and Analgesic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Pfizer Antipyretic and Analgesic Drugs Product
 Table 84. Pfizer Recent Developments/Updates
 Table 85. Sanofi Company Information
 Table 86. Sanofi Description and Business Overview
 Table 87. Sanofi Antipyretic and Analgesic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Sanofi Antipyretic and Analgesic Drugs Product
 Table 89. Sanofi Recent Developments/Updates
 Table 90. Bayer Company Information
 Table 91. Bayer Description and Business Overview
 Table 92. Bayer Antipyretic and Analgesic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Bayer Antipyretic and Analgesic Drugs Product
 Table 94. Bayer Recent Developments/Updates
 Table 95. China National Medicines Guorui Pharmaceutical Company Information
 Table 96. China National Medicines Guorui Pharmaceutical Description and Business Overview
 Table 97. China National Medicines Guorui Pharmaceutical Antipyretic and Analgesic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. China National Medicines Guorui Pharmaceutical Antipyretic and Analgesic Drugs Product
 Table 99. China National Medicines Guorui Pharmaceutical Recent Developments/Updates
 Table 100. Baotai Pharmaceutical Company Information
 Table 101. Baotai Pharmaceutical Description and Business Overview
 Table 102. Baotai Pharmaceutical Antipyretic and Analgesic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Baotai Pharmaceutical Antipyretic and Analgesic Drugs Product
 Table 104. Baotai Pharmaceutical Recent Developments/Updates
 Table 105. Huaan Pharmaceutical Company Information
 Table 106. Huaan Pharmaceutical Description and Business Overview
 Table 107. Huaan Pharmaceutical Antipyretic and Analgesic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Huaan Pharmaceutical Antipyretic and Analgesic Drugs Product
 Table 109. Huaan Pharmaceutical Recent Developments/Updates
 Table 110. Yuanhe Pharmaceutical Company Information
 Table 111. Yuanhe Pharmaceutical Description and Business Overview
 Table 112. Yuanhe Pharmaceutical Antipyretic and Analgesic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Yuanhe Pharmaceutical Antipyretic and Analgesic Drugs Product
 Table 114. Yuanhe Pharmaceutical Recent Developments/Updates
 Table 115. Heping Pharmaceutical Company Information
 Table 116. Heping Pharmaceutical Description and Business Overview
 Table 117. Heping Pharmaceutical Antipyretic and Analgesic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Heping Pharmaceutical Antipyretic and Analgesic Drugs Product
 Table 119. Heping Pharmaceutical Recent Developments/Updates
 Table 120. Hongxing Pharmaceutical Company Information
 Table 121. Hongxing Pharmaceutical Description and Business Overview
 Table 122. Hongxing Pharmaceutical Antipyretic and Analgesic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Hongxing Pharmaceutical Antipyretic and Analgesic Drugs Product
 Table 124. Hongxing Pharmaceutical Recent Developments/Updates
 Table 125. Xinhui Pharmaceutical Company Information
 Table 126. Xinhui Pharmaceutical Description and Business Overview
 Table 127. Xinhui Pharmaceutical Antipyretic and Analgesic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Xinhui Pharmaceutical Antipyretic and Analgesic Drugs Product
 Table 129. Xinhui Pharmaceutical Recent Developments/Updates
 Table 130. Dingchang Pharmaceutical Company Information
 Table 131. Dingchang Pharmaceutical Description and Business Overview
 Table 132. Dingchang Pharmaceutical Antipyretic and Analgesic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Dingchang Pharmaceutical Antipyretic and Analgesic Drugs Product
 Table 134. Dingchang Pharmaceutical Recent Developments/Updates
 Table 135. Topfond Pharmaceutical Company Information
 Table 136. Topfond Pharmaceutical Description and Business Overview
 Table 137. Topfond Pharmaceutical Antipyretic and Analgesic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Topfond Pharmaceutical Antipyretic and Analgesic Drugs Product
 Table 139. Topfond Pharmaceutical Recent Developments/Updates
 Table 140. Taile Pharmaceutical Company Information
 Table 141. Taile Pharmaceutical Description and Business Overview
 Table 142. Taile Pharmaceutical Antipyretic and Analgesic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. Taile Pharmaceutical Antipyretic and Analgesic Drugs Product
 Table 144. Taile Pharmaceutical Recent Developments/Updates
 Table 145. Kys Pharm Company Information
 Table 146. Kys Pharm Description and Business Overview
 Table 147. Kys Pharm Antipyretic and Analgesic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 148. Kys Pharm Antipyretic and Analgesic Drugs Product
 Table 149. Kys Pharm Recent Developments/Updates
 Table 150. China Resources Double-Crane Pharmaceutical Company Information
 Table 151. China Resources Double-Crane Pharmaceutical Description and Business Overview
 Table 152. China Resources Double-Crane Pharmaceutical Antipyretic and Analgesic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 153. China Resources Double-Crane Pharmaceutical Antipyretic and Analgesic Drugs Product
 Table 154. China Resources Double-Crane Pharmaceutical Recent Developments/Updates
 Table 155. Key Raw Materials Lists
 Table 156. Raw Materials Key Suppliers Lists
 Table 157. Antipyretic and Analgesic Drugs Distributors List
 Table 158. Antipyretic and Analgesic Drugs Customers List
 Table 159. Antipyretic and Analgesic Drugs Market Trends
 Table 160. Antipyretic and Analgesic Drugs Market Drivers
 Table 161. Antipyretic and Analgesic Drugs Market Challenges
 Table 162. Antipyretic and Analgesic Drugs Market Restraints
 Table 163. Research Programs/Design for This Report
 Table 164. Key Data Information from Secondary Sources
 Table 165. Key Data Information from Primary Sources
 Table 166. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Antipyretic and Analgesic Drugs
 Figure 2. Global Antipyretic and Analgesic Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Antipyretic and Analgesic Drugs Market Share by Type: 2024 & 2031
 Figure 4. Ibuprofen Product Picture
 Figure 5. Paracetamol Product Picture
 Figure 6. Analgin Product Picture
 Figure 7. Naproxen Product Picture
 Figure 8. Aspirin Product Picture
 Figure 9. Others Product Picture
 Figure 10. Global Antipyretic and Analgesic Drugs Market Value by Application (2020-2031) & (US$ Million)
 Figure 11. Global Antipyretic and Analgesic Drugs Market Share by Application: 2024 & 2031
 Figure 12. Hospital
 Figure 13. Clinic
 Figure 14. Global Antipyretic and Analgesic Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Antipyretic and Analgesic Drugs Market Size (2020-2031) & (US$ Million)
 Figure 16. Global Antipyretic and Analgesic Drugs Sales (2020-2031) & (K Units)
 Figure 17. Global Antipyretic and Analgesic Drugs Average Price (US$/Unit) & (2020-2031)
 Figure 18. Antipyretic and Analgesic Drugs Report Years Considered
 Figure 19. Antipyretic and Analgesic Drugs Sales Share by Manufacturers in 2024
 Figure 20. Global Antipyretic and Analgesic Drugs Revenue Share by Manufacturers in 2024
 Figure 21. Global 5 and 10 Largest Antipyretic and Analgesic Drugs Players: Market Share by Revenue in Antipyretic and Analgesic Drugs in 2024
 Figure 22. Antipyretic and Analgesic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 23. Global Antipyretic and Analgesic Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 24. North America Antipyretic and Analgesic Drugs Sales Market Share by Country (2020-2031)
 Figure 25. North America Antipyretic and Analgesic Drugs Revenue Market Share by Country (2020-2031)
 Figure 26. United States Antipyretic and Analgesic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Canada Antipyretic and Analgesic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Europe Antipyretic and Analgesic Drugs Sales Market Share by Country (2020-2031)
 Figure 29. Europe Antipyretic and Analgesic Drugs Revenue Market Share by Country (2020-2031)
 Figure 30. Germany Antipyretic and Analgesic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. France Antipyretic and Analgesic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. U.K. Antipyretic and Analgesic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Italy Antipyretic and Analgesic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Russia Antipyretic and Analgesic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Asia Pacific Antipyretic and Analgesic Drugs Sales Market Share by Region (2020-2031)
 Figure 36. Asia Pacific Antipyretic and Analgesic Drugs Revenue Market Share by Region (2020-2031)
 Figure 37. China Antipyretic and Analgesic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Japan Antipyretic and Analgesic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. South Korea Antipyretic and Analgesic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. India Antipyretic and Analgesic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Australia Antipyretic and Analgesic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. China Taiwan Antipyretic and Analgesic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Southeast Asia Antipyretic and Analgesic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America Antipyretic and Analgesic Drugs Sales Market Share by Country (2020-2031)
 Figure 45. Latin America Antipyretic and Analgesic Drugs Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico Antipyretic and Analgesic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil Antipyretic and Analgesic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina Antipyretic and Analgesic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Middle East and Africa Antipyretic and Analgesic Drugs Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Antipyretic and Analgesic Drugs Revenue Market Share by Country (2020-2031)
 Figure 51. Turkey Antipyretic and Analgesic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Antipyretic and Analgesic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. UAE Antipyretic and Analgesic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Global Sales Market Share of Antipyretic and Analgesic Drugs by Type (2020-2031)
 Figure 55. Global Revenue Market Share of Antipyretic and Analgesic Drugs by Type (2020-2031)
 Figure 56. Global Antipyretic and Analgesic Drugs Price (US$/Unit) by Type (2020-2031)
 Figure 57. Global Sales Market Share of Antipyretic and Analgesic Drugs by Application (2020-2031)
 Figure 58. Global Revenue Market Share of Antipyretic and Analgesic Drugs by Application (2020-2031)
 Figure 59. Global Antipyretic and Analgesic Drugs Price (US$/Unit) by Application (2020-2031)
 Figure 60. Antipyretic and Analgesic Drugs Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String

SIMILAR REPORTS